Search

everythinglearnresearchcommunity

for

Search:↓

RU58841, a substance from France, can potentially block the effects of hormones that cause hair loss and excessive hair growth, performing better than a similar substance, cyproterone acetate.

The top research priorities for congenital ichthyosis include long-term side effects of oral retinoids, best topical treatments, and treatments for itch and hair loss.

Some people may temporarily lose more hair in certain areas after a hair transplant.

Mycophenolate mofetil may improve symptoms and stop hair loss in Lichen planopilaris, but more research is needed.

Lichen planus pigmentosus and fibrosing frontal alopecia in Colombia are likely different stages of the same disease.

Acne inversa is an epithelial-driven disease where inflammation is caused by cyst rupture, and treatments should focus on preventing tendril growth for better results.

Antiandrogenic drugs could be a good treatment option for frontal fibrosing alopecia.

Common baldness treatments include cosmetic methods, medication like minoxidil, and surgery, but no cure exists.

Patients and doctors often differ in assessing hair loss severity, so treatment should be personalized.

Intralesional corticosteroid injections effectively treat scalp vitiligo.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Topical cyclosporin A doesn't work for alopecia totalis because it doesn't penetrate the skin well.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Fisetin may help treat psoriasis and reduce skin inflammation.

Patients with ichthyosis often experience symptoms similar to psoriasis and atopic dermatitis, suggesting that targeted therapies could improve their condition.

Topical tacalcitol ointment can help improve symptoms of EFFC.

Low-intensity light therapy is effective for skin healing, reducing inflammation, and treating various skin conditions.

Understanding how melanocyte stem cells work could lead to new treatments for hair graying and skin pigmentation disorders.

High platelet numbers in PRP may not be essential for hair growth, and certain growth factors could negatively affect treatment outcomes for hair loss.

A new tool can predict hair regrowth in patchy alopecia areata patients.

SM04755 may be an effective topical treatment for psoriasis.

SIG-1451 could be a promising new treatment for atopic dermatitis.

Cilostazol may help hair grow and could be a new treatment for hair loss.

Tildrakizumab significantly improved recalcitrant lichen planopilaris and frontal fibrosing alopecia.

The document concludes that various topical treatments show promise for skin conditions like atopic dermatitis, psoriasis, and hair loss.

Identical p53 gene mutations in different cancers suggest the need for careful treatment.

A man with Acrodermatitis continua did not get better with etanercept treatment, and his condition worsened, suggesting treatment effectiveness may vary by genetics and race.

Improper regulation of hair follicle processes causes hairlessness.

Using DNase enzymes to break down harmful NETs could be a new treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis.

SM04554 may increase hair growth as a topical treatment for androgenetic alopecia.